Medical Devices Approval Process

Slides:



Advertisements
Similar presentations
Development Cycle of Medical Devices: A Path of Opportunities for Information Professionals Donna Gay Pharma & Health Tech Div, SLA 2007 Spring Meeting.
Advertisements

Regulatory Pathway for Platform Technologies
Entering the US Market: Medical Devices
Overview of FDA Device Regulations
Regulation of Medical Devices Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation.
Overview of Device Regulations David Arvelo Small Business Representative.
"Determining the Regulatory Pathway to Market" Classification Heather S. Rosecrans Director, 510(k) Staff Office of Device Evaluation Center for Devices.
510k Submission Overview Myraqa, Inc. August 22, 2012.
Medical Device Submissions
University of Medicine and Dentistry of New Jersey John L. Ricci, Ph.D., Department of Orthopaedics History and Scope of Biomaterials J. L. Ricci, Ph.D.
Special Topics in IND Regulation
Donna M. Liewer FCLB Executive Director Understanding the FDA: Key Considerations for Regulatory Agencies.
The FDA Landscape AdvaMed September 2008 Judith K. Meritz
+ Medical Devices Approval Process. + Objectives Define a medical device Be familiar with the classification system for medical devices Understand the.
Weaving regulations into sound value analysis processes Barbara Strain, MA, SM(ASCP) Director Value Management University of Virginia Health System.
Unique Device Identification and Global Medical Device Nomenclature Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration
Classification of HLA Devices FDA Introduction & Background Sheryl A. Kochman CBER/OBRR/DBA.
Life cycle of medical devices Gerald Verollet World Health Organization 3rd SIGN Meeting - New Delhi.
Radiological Devices Advisory Committee Meeting November 18, 2009 John A. DeLucia iCAD, Inc.
Product Definition Chapter 4. What is a Medical Device? FDA: “an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent,
1 THE UNIQUE ROLES OF IRB IN MEDICAL DEVICE CLINICALL TRIAL Chiu Lin, Ph.D. CITI, May, 2009 CITI, May, 2009.
Device Research Presented by Marian Serge, R.N.. Goals Identify devices Recognize difference between significant risk (SR) and non- significant risk (NSR)
Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.
Prof. Moustafa M. Mohamed Vice dean Faculty of Allied Medical Science Pharos University in Alexandria Development and Regulation of Medical Products (MEDR-101)
The Medical Device Pathway as a Legal Onramp for Futuristic Persons THE FUTURE T HE M EDICAL D EVICE P ATHWAY AS A L EGAL.
1 Importation of Medical Devices FDA Chicago District O’Hare Import Resident Post August 26, 2010 Import Entry Review Team Tamara M. Qtami, CSO.
Medical Devices IRB Determination IRB Member Continuing Education.
Compliance with FDA Regulations: Collecting, Transmitting and Managing Clinical Information Dan C Pettus Senior Vice President iMetrikus, Inc.
Changes to the Therapeutic Goods Act and its implications Prepared by: Anna Frazer Prosthetist Hunter Prosthetics & Orthotics Service 10 th November 2006.
FDA Focus On Consumer Protection
510(k) Process: Best Practices in Changing Times… MassMEDIC Massachusetts Medical Society, Waltham, MA April 1, :00 AM - 10:30 AM.
1 CONSENSUS STANDARDS OIVD WORKSHOP April 22-23, 2003 Rockville MD Ginette Y. Michaud, M.D. OIVD.
Utah Life Science Summit Nov Phil Triolo, PhD RAC President, Phil Triolo and Associates LC.
Regulatory Decision Making D. Kathleen Wright, Reviewer Division of Microbiology Office of In Vitro Diagnostic Device Evaluation & Safety ( OIVD ) Food.
The Food and Drug Administration Allison Kotchman Victoria Gilbride.
UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.
General Regulatory Issues in the Development of Drugs Intended for Treatment of Chronic Illness Sharon Hertz, M.D. Medical Officer Division of Anesthetic,
Hemoglobin Device Regulation Josephine Bautista, M.S., MT (ASCP) Senior Advisor for IVD Regulation DRB/DBA/OBRR/CBER Workshop: Hemoglobin standards and.
REGULATION OF MEDICAL DEVICES INNOVATION TUĞÇE YAŞAR
AMERICAS | ASIA PACIFIC | EMEA Medical Devices: Concept to Commercialization How to avoid delays in getting your product cleared/approved by FDA Robert.
Radiology Advisory Panel Meeting Radiology Advisory Panel Meeting Computer-Assisted Detection (CADe) Devices Joyce M. Whang Deputy Division Director Radiological.
Moj Eram, PhD Senior Consultant ARC Experts, LLC 6 April, 2016
Regulation of Medical Devices: Tanzania experience Fimbo, A. M Tanzania Food and Drugs Authority.
CONSIDERATIONS FOR SURGICAL MEDICAL DEVICE TRIALS LCTU Liverpool Clinical Trials Unit Considerations for Medical Device Trials.
Device Updates in FDASIA MDUFA III RA SAIC – 9 th April 2013 Karen Jaffe, MS, MBA, RAC or
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
Complaint Handling Medical Device Reporting May 19, 2016 Rita Harden, Director Customer Relations & Regulatory Reporting.
PD233: Design of Biomedical Devices and Systems (Lecture 2) Dr. Manish Arora CPDM, IISc Course Website:
NOTE: To change the image on this slide, select the picture and delete it. Then click the Pictures icon in the placeholder to insert your own image. National.
November 9, 2015 February 20, 2017 Using real world evidence – industry perspective Pma indication expansion Melissa hasenbank, phd Sr. Clinical Research.
Executive Director, Registrar Corp
Use of Postmarket Data to Support Premarket Approvals
GCP AND MEDICAL DEVICES
The Food and Drug Administration
Division of Cardiovascular Devices
Premarket Notification 510(k) process
FDA’s IDE Decisions and Communications
FDA Perspective on Cardiovascular Device Development
Update on the National Postmarket Surveillance System
Overview of regulatory and compliance in software development for medical devices
Medical Device Regulatory Essentials: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD, FACC Director, FDA Division of Cardiovascular.
Get Ready for FDA Oversight of Laboratory Developed Tests Presenter:
FDA-CDRH in the Next Decade A Vision for Change
Device Review Decision Tree Version Date: 4/28/15 This decision tree to be used for studies involving research on a device ( approved or unapproved)
HL7 International January Working Group Meeting Health Care Device WG
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Implantable Medical Devices: Accelerating Standards Development to Streamline Regulation Joshua Price | August 2,
Linda M. Chatwin, Esq. RAC Business Manager, UL LLC
NEW MDR Regulatory Context. NEW MDR Regulatory Context.
MEDICAL DEVICES CONTROL SYSTEM IN INDONESIA
Presentation transcript:

Medical Devices Approval Process APGO Interaction with Industry: A Medical Student Guide Medical Devices Approval Process Rev. 10/21/2014

Learning Objectives Define a medical device Explain the classification system for medical devices Understand the difference between 510(k) Premarket Notification and Premarket Approval for Class II and III devices Describe the goals of the National Postmarket Medical Device Surveillance System Define Unique Device Identification (UDI) system and describe how it is used

What is a Medical Device? Defined by the Food, Drug, and Cosmetic Act of 1938 as: an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part, or accessory which is: Used to diagnose, prevent, or treat a disease or other condition Does not achieve its purpose through chemical action within or on the body (which would make it a drug) Thus medical devices fall under the jurisdiction of the FDA

Classification of Medical Devices Medical devices are classified into Class I, II, and III Regulatory control increases from Class I to Class III Class I General controls Class II General controls with special controls Class III General controls and premarket approval

Class I Devices: General Controls Class I: Devices for which general controls are sufficient to provide reasonable assurance of safety and effectiveness Examples: scalpels, tongue depressors

Class II Devices: General Controls with Special Controls Class II: Devices for which general controls alone are insufficient to establish safety and effectiveness. Must meet general controls as well as special controls Special Controls are: Performance standards Postmarket surveillance Patient registries, guidelines recommendations, and “other appropriate actions” Examples: Laser for general surgery, diagnostic ultrasound, many intravascular devices Most require a 510k premarket notification

Premarket Notification 510k 510k is a premarket submission to the FDA that demonstrates that the device is substantially equivalent to a legally marketed device What is “substantially equivalent”? The device: Has the same use Has the same technological characteristics Does not require same clinical research as required of medications or Class III devices

Class III Devices: General Controls and Premarket Approval Class III: Devices for which general and special controls alone are not sufficient to establish safety and efficacy: (i) used in supporting or sustaining human life or (ii) are for a use which is of substantial importance in preventing impairment of human health or (iii) present a potential unreasonable risk of illness or injury Examples: artificial hearts, laser for ophthalmic surgery, many spinal implants Most require premarket approval

Premarket Approval Class III devices are subject to premarket approval (PMA) Could be Class III because of high risk or because of lack of predicate device Approval involves submission of clinical data to support claims made by the device manufacturers

Premarket Approval (cont’d) Class II devices require premarket notification via 510k, meaning the device is substantially equivalent to an existing device. Class III devices require premarket approval, a much more stringent process

Investigational Device Exemption Is still in the developmental stage Is the object of a clinical investigation to determine safety and effectiveness Is not considered to be in commercial distribution Investigational Use Clinical evaluation of a legally marketed device for a new intended use

2013 National Postmarket Medical Device Surveillance System: Goals Communicates data-based assessments of the medical risks and benefits of medical devices throughout their marketed life Identifies possible safety issues in near real-time from a variety of data sources Reduces burdens and costs of postmarket surveillance Facilitates approval of new devices or new uses for existing devices Led to creation of a Unique Device Identification System (UDI)

Unique Device Identification (UDI) System The FDA began requiring a UDI system in September 2013 Global UDI Database (GUDID) to provide non- confidential device information to stakeholders and general public Incorporate UDI information into health records through EMRs FDA is also promoting development of International Medical Device Registry for selected products

Example of Fictitious UDI Label Product name Expiration date Reference and lot numbers Manufacturer information Bar code Details about the item

Expedited Process Premarket Approval Application Program Established April 2014 FDA response to criticisms that approval process for Class III devices is too inefficient and slow An attempt to improve patient access to new, helpful products A device may be eligible if it features breakthrough technology with significant benefits over existing products

Resources (hyperlinks will be active in presentation mode) http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/Ov erview/default.htm http://www.fda.gov/medicaldevices/deviceregulationandguidance/over view/classifyyourdevice/ucm051512.htm http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/Uni queDeviceIdentification/default.htm http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm 394294.htm